Skip to content

Author

V. Asati

We have 4 of 132 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Exploring the antidiabetic potential of DHA-salicylaldehyde-chalcone endowed 1,2,3-triazole hybrids: synthesis, α-glucosidase inhibition and molecular modeling studies.

The hybrid 4k exhibited maximum inhibition of α-glucosidase enzyme with favorable binding interactions, suggesting this framework is a potential lead motif for future antidiabetic drug discovery.

Anshul Grover, V. Asati, Jayant Sindhu et al. · 0 citations
Review Aug 2026

Recent Updates on Novel Quinazoline‐Hybrid Molecules Possessing EGFR‐Mediated Anticancer Activity

The structure–activity relationship (SAR) and cytotoxic activity of several quinazoline derivatives with demonstrated EGFR‐inhibitory antiproliferative activity and the EGFR‐mediated anticancer potential of quinazoline derivatives discovered after 2020 are reported.

Ankur Vaidya, Shweta Jain, B. Kumar et al. · 0 citations
Review Open access Jul 2026

AI-driven computational drug design: tools, workflow and challenges

This review focuses on the AI-based approaches for target discovery, virtual screening, molecular generation, lead optimization, retro-synthesis, and structural modeling while also addressing issues of dataset bias, reproducibility, and real-world applicability.

Ryena Dhir, Pitam Ghosh, Dinki Sharma et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.